FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Acadia Boasts Favorable Phase 3 Results in Parkinsons Trial

[ Price : $8.95]

Acadia Pharmaceuticals says a pivotal Phase 3 trial evaluating the efficacy, tolerability and safety of pimavanserin in patients w...

FDA Approves Cobrek Pharma Generic Luxiq Foam

[ Price : $8.95]

FDA approves a Cobrek Pharmaceuticals ANDA for betamethasone valerate foam 0.12%, the generic equivalent of Stiefels Luxiq Foam.

FDA Clears AtCor Medical Blood Pressure Device

[ Price : $8.95]

FDA clears an AtCor Medical 510(k) for its SphygmoCor XCEL device, a new blood pressure cuff-based system that allows brachial and...

Quality, Reporting Problems Found at Nexera

[ Price : $8.95]

FDAs Florida District Office warns Nexera Medical about Quality System and Medical Device Reporting violations in its manufacturin...

DTC Ads Improve Consumer Welfare: Study

[ Price : $8.95]

Health economist Jayani Jayawardhana says her research shows that drug DTC ads help improve consumer welfare by promoting treatmen...

Higher Death Risk for Some Vibativ Patients: Reviewers

[ Price : $8.95]

FDA medical reviewers tell the Anti-infective Drugs Advisory Committee that Theravances Vibativ may pose a higher risk of death fo...

Phoenix Instruments Warned About QS Violations

[ Price : $8.95]

FDAs Chicago District Office warns Phoenix Instruments about Quality System and Medical Device Reporting violations in its facilit...

DTC Campaign Launched for Sleep Aid Intermezzo

[ Price : $8.95]

Transcept Pharmaceuticals says its U.S. partner, Purdue Pharmaceutical Products, is launching a $29 million national direct-to-con...

Latest FDA Warning Letters

[ Price : $8.95]

In its latest batch of Warning Letters, FDA cites Health Technology, InControl Medical, Integra NeuroSciences, Mi Gwang Contact Le...

Ranbaxy Under Scrutiny After Generic Lipitor Recall

[ Price : $8.95]

Ranbaxy recalls dozens of lots of generic Lipitor after detecting small glass particles in some batches, a move that is likely to ...